Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Wikipedia
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.
People also ask
What is the Alexion Pharmaceuticals controversy?
Did AstraZeneca buy Alexion Pharmaceuticals?
What drugs do Alexion make?
Is Alexion a good company?
Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to ...
Alexion Pharmaceuticals, Inc. Biotechnology Research. Boston, Massachusetts 349,664 followers. Rare inspiration. Changing lives. See jobs Follow.
Jul 2, 2020 · Without admitting or denying the SEC's findings, Alexion agreed to cease and desist from committing violations of the books and records and ...
Alexion to Buy Synageva BioPharma in $8.4 Billion Deal. The deal taps into the interest for so-called orphan drugs, where companies can charge hundreds of ...
Mar 12, 1999 · Alexion Pharmaceuticals, Inc. | 350253 followers on LinkedIn. Rare inspiration. Changing lives. | Alexion, AstraZeneca Rare Disease was ...
Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the ...